HIGHLIGHTS
- who: Age-d Ovarian Cancer and colleagues from the Department I of Obstetrics and Gynecology, Cangzhou Central Hospital, Cangzhou, China have published the paper: m6A-Related lncRNA Signature Is Involved in Immunosuppression and Predicts the Patient Prognosis of the Age-Associated Ovarian Cancer, in the Journal: Journal of Immunology Research of 10/08/2022
- what: To discover the biological mechanisms of the lncRNA signature functions, the authors seek the pathways on which the lncRNA signature was enriched. To clarify the immune landscape, the authors explore the immunocyte infiltration via analysis of 28 tumor-infiltrating lymphocytes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.